The key things to look for in an income statement while doing NovaBay Pharma stock analysis are: Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you …
This is a technical analysis stock rating for NovaBay Pharmaceuticals Inc (AMEX:NBY) . The company has a four bull technical rating which indicates some strength. The risk here is a potentially overbought situation, but for …
Novabay Pharmaceuticals (NBY): NBY stock is up 8.29% today ... Article printed from InvestorPlace Media, http://investorplace.com/2016/01/biggest-movers-in-manufacturing-stocks-now-nby-vbiv-mitk-iti/.
NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing ... Register now to create your own custom streaming stock watchlist. NYSE, AMEX, and ASX quotes are …
LD
NovaBay Pharma (NYSE: NBY) announced the pricing of an underwritten public offering of 12,300,000 shares of common stock and common stock purchase warrants to purchase up to 11,070,000 shares of common stock
per share in the same period the prior year NBY stock continued its upward move and surged more than 10% in after-hours trading NovaBay Pharmaceuticals, which develops and commercializes non-antibiotic anti-infective …
MONTREAL, QUEBEC--(Marketwired - Dec. 22, 2016) - Niobay Metals Inc. (the "Company") (TSX VENTURE:NBY) announces that its board of directors has approved a new "rolling 10%" stock option plan (the …
The stock of NovaBay Pharmaceuticals, Inc. (NYSEMKT:NBY) is a huge mover today! The stock decreased 18.00% or $0.9 on November 11, hitting $4.1. About 87,799 shares traded hands or 33.73% up from the …
NovaBay Pharmaceuticals (NBY) plummeted to a 52-week low Wednesday after the company announced its potential adenoviral conjunctivitis treatment did not meet its endpoints in a Phase 2 clinical study. Novabay …